Find your tools for building human cell-based models & screening assays
Featured Product
Microglia
Human iPSC-derived Microglia provide a reliable and consistent model that phenotypically recapitulates human microglia responses in vitro.
Featured Service
Cell Reprogramming
A complete suite of custom cell reprogramming and characterization services from dedicated specialists to generate iPSCs from human cells using cutting edge technologies.
Featured White Paper
Atrial Cardiomyocytes
Are you using non-human cell models for your cardiac research? Download our new white paper to find out why human iPSC-derived Atrial Cardiomyocytes could improve your data.
Welcome to Axol Bioscience
YOUR HUMAN CELL CULTURE SPECIALISTS
We provide highly validated human iPSC-derived cells and primary cells from healthy donors and patients of specific disease backgrounds, together with optimized media and growth supplements. Axol aims to develop the best human cell biology research tools to advance medical research and drug discovery. Combining our passion for science with quality, innovation and customer service, we deliver robust and reliable products that our customers need to advance their research faster.
Make the Switch to Mature Human Sensory Neurons - In 3 Weeks
29 June 2021
Millions of people around the world suffer from debilitating pain. However impressive advances are being made in neural stem cell R&D to advance pain research and drug discovery efforts. Robust, translational assays using human iPSC-derived Sensory Neurons enable researchers to delve deeper into the molecular pathways underpinning pain, to ultimately improve both the screening of drug candidates and the quality of life for people across the world.
Bioengineering the Human Neuromuscular Junction (NMJ)
9 June 2021
Loughborough University scientists use Axol motor neurons to bioengineer a 3D human model of the neuromuscular junction (NMJ), opening the door to translational assays for use in drug development for motor neuron disease.
Can We Model Neuroimmune Diseases in a Dish?
6 May 2021
Following Axol Bioscience and Censo Biotechnologies recent merger to form Axol Biosciences, our CSO Ashley Barnes was
invited to speak at the Neuroimmunology Drug Development Summit
alongside other experts from academia and industry on the advances being
made in this burgeoning field.
In this article we feature his answers to some of the pressing questions that arose from the audience and the field.
Better Assays Are Key to Understanding Neurological Conditions Caused by COVID-19
27 April 2021
In a recent study
from the University of Oxford, UK, and TriNetX, US, scientists explored
the electronic health records of 236,379 COVID-19 patients and
estimated that one-in-three COVID-19 survivors (34%) were diagnosed with
a neurological or psychiatric condition within the first six months
following infection.
Axol Bioscience is a Key Participant in the European Union's Horizon 2020 Research Programme
24 March 2021
Axol Bioscience is a significant UK Partner
in the Platforma initiative.
How to Order
To place an order or request a quotation simply add the desired products to your shopping cart and then click "Process Checkout" to provide the billing and shipping information. On the payment page you can then either pay immediately or download a quotation.
Order Confirmed
Thank you for your order. We have received your purchase order successfully and will start processing it as soon as possible.
We will be in touch shortly.
Issue with Order Detected
There was an issue with your submitted order as follows: Unidentified Error Please resolve this issue and try again. If you are unable to do so, please contact us via the contact form and we'll do our best to resolve your issue.
